Antihypertensive therapy should be administered to individuals with hypertension and PAD to scale back the potential risk of MI, stroke, heart failure, and cardiovascular death.9 Angiotensin-converting enzyme inhibitors directly inhibit the atherosclerotic course of action and improve vascular endot